Erzsébet Merényi, a statistics research professor at Rice University, and co-investigators at The University of Texas MD Anderson Cancer Center Pratip Bhattacharya, professor of cancer systems imaging ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

MELBOURNE, Australia and PORTO ALEGRE, Brazil, March 18, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health ...

Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today announces that the Brazilian Health ...

DelveInsight's "VERZENIO Market Size, Forecast, and Market Insight Report" highlights the details around VERZENIO, which is a targeted treatment known as ...

Isotopia, a leading developer of innovative radio-pharmaceuticals, has officially launched Isoprotrace® in Germany. DSD ...

The Global Fusion Biopsy Market Size is projected to grow at a CAGR of 8.9% from 2025 to 2032, according to a new report published by Verified Market Research ®. The report reveals that the market was ...

We know that a colonoscopy is the most effective tool for the early detection and prevention of colon cancer. But anyone who has ever had a colonoscopy also knows that it's not necessarily ...

Two weeks after finishing a marathon, John Johnson was diagnosed with Stage 2 colorectal cancer. He shares his story to raise awareness and offer hope. As John Johnson trained for his second ...

Thousands of men are to be checked for prostate cancer in one of the first large-scale European trials of smart screening. The pilot study, starting next week in Ireland, will combine a blood test ...

Auburn coach Hugh Freeze was recently diagnosed with an early form of prostate cancer, the school announced Friday. He is expected to make a full recovery and will continue his normal coaching ...

By examining billing codes in Medicare hospital outpatient and carrier claims, they identified 17,609 patients from across the country who died of breast, lung, colorectal or prostate cancer from 2012 ...